The hullabaloo has been boiling about what form of federal agency will have responsibility for funding cancer research—whether the National Cancer Institute or a new National Cancer Authority separate from the National Institutes of Health. Cohen1 takes the stance that the lodgement of authority does not matter so long as the authority is best adapted to the problems and does not distort other medical and scientific needs. He boldly states that present forms have failed to supply adequate intellectual and monetary support. He adds, furthermore, that an appropriate administrative form can not be devised until goals, programs, and priorities are well defined.
Cohen briefly reviews the progress in cancer research during recent decades and finds hope in the fact that new knowledge "... in cellular biology has made the study of cancer and cancer cells an appropriate subject of detailed analysis." However, he believes that cancer research activi ties in
Cancer Conquest. JAMA. 1971;217(12):1697–1698. doi:10.1001/jama.1971.03190120063014